financetom
Business
financetom
/
Business
/
Taylor Morrison Home Insider Sold Shares Worth $9,894,120, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taylor Morrison Home Insider Sold Shares Worth $9,894,120, According to a Recent SEC Filing
Mar 25, 2024 1:54 PM

04:22 PM EDT, 03/25/2024 (MT Newswires) -- William H Lyon, Director, on March 21, 2024, sold 164,000 shares in Taylor Morrison Home ( TMHC ) for $9,894,120. Following the Form 4 filing with the SEC, Lyon has control over a total of 61,314 shares of the company, with 17,744 shares held directly and 43,570 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1562476/000095014224000777/xslF345X03/es240461152_4-lyon.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PJT Partners Shares Rise After Q1 Beat
PJT Partners Shares Rise After Q1 Beat
May 2, 2024
12:14 PM EDT, 05/02/2024 (MT Newswires) -- PJT Partners ( PJT ) shares rose more than 6% in recent Thursday trading after the company's Q1 results beat market expectations. The investment bank reported Q1 diluted earnings of $0.98, up from $0.54 a year earlier. Analysts polled by Capital IQ expected $0.45. Revenue for the quarter ended March 31 was $329.4...
--Toronto-Dominion Bank Fined $6.7 Million by Canadian Regulator Over Anti-Money Laundering Non-Compliance
--Toronto-Dominion Bank Fined $6.7 Million by Canadian Regulator Over Anti-Money Laundering Non-Compliance
May 2, 2024
12:23 PM EDT, 05/02/2024 (MT Newswires) -- Price: 58.86, Change: +0.16, Percent Change: +0.28 ...
Kymera Therapeutics Q1 Net Loss Narrows, Collaboration Revenue Rises
Kymera Therapeutics Q1 Net Loss Narrows, Collaboration Revenue Rises
May 2, 2024
12:18 PM EDT, 05/02/2024 (MT Newswires) -- Kymera Therapeutics ( KYMR ) reported a Q1 net loss Thursday of $0.69 per diluted share, narrower than a loss of $0.70 a year earlier. Analysts polled by Capital IQ expected a loss of $0.73. Collaboration revenue for the quarter ended March 31 was $10.3 million, up from $9.5 million a year earlier....
Frontdoor Q1 EPS, Revenue Surpass Expectations, Maintains 2024 Outlook; Shares Rise
Frontdoor Q1 EPS, Revenue Surpass Expectations, Maintains 2024 Outlook; Shares Rise
May 2, 2024
12:25 PM EDT, 05/02/2024 (MT Newswires) -- Frontdoor ( FTDR ) shares advanced Thursday, recently climbing almost 6%, following its better-than-expected Q1 results. Earlier, the company reported Q1 adjusted net income of $0.44 per diluted share, compared with $0.29 a year earlier. Analysts polled by Capital IQ expected $0.20. Revenue for the quarter ended March 31 was $378 million, up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved